Underlying Co-Morbidity Reveals Unique Immune Signatures in Type II Diabetes Patients Infected With SARS-CoV2.
Front Immunol. 2022 Apr 27;13:848335. doi: 10.3389/fimmu.2022.848335. eCollection 2022.
Front Immunol. 2022.
PMID: 35572555
Free PMC article.